• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Eisai`s Kisplyx (lenvatinib mesilate) Receives Approval for Europe

    EMA

    Eisai, MSD start marketing activity for LENVIMA

    BIOSPECTRUM

    Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)

    NASDAQ

    Eisai & Merck Receive Breakthrough Therapy Designation from FDA for LENVIMA

    PR NEWSWIRE

    PhIII of Anticancer Agent Lenvima Meets Primary Endpoint

    PRESS RELEASE

    Eisai`s Gets EU Nod For Cancer Medicine Kisplyx

    EMA

    Eisai receives license for new indication for anticancer agent Kisplyx

    BIOSPECTRUM

    Eisai receives positive CHMP opinion on new indication for anticancer agent

    BIOSPECTRUM ASIA

    Eisai signs with Novartis for Lenvima sales effort in U.S.

    PRESS RELEASE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.